FIELD: chemistry.
SUBSTANCE: genetic predisposition is determined by analysing polymorphism of genes ACTN3 (R577X), CNB (5I/5D), AMPD1 (C34T) through a multiplex polymerase chain reaction. For this purpose, a set of primers is used, wherein for the gene ACTN3 (R577X) the primes used are ACTGCTGCCCTTTCTGTTGCCT-3' and S'-CTGCAGGTGGCACTGACCATA3', for the gene CNB (5I/5D) the primers used are 5'-GGAGTTTAAAAGCCAGCCAGTCATACTA-3' and 5'-TGGAAGATCACACCATTTGATTAGCAGT-3', for the geneAMPD1 (C34T) the primers used are S'-GCAATCTACATGTGTCTACCCCAAAG-3' and 5'-CACTGCTGAAAAATAGCCATGTTTCTG-3'. Further, 3 pairs of primers with average melting point of 58-59°C are merged in a single test tube at standard conditions. The reaction product is analysed through analysis of polymorphism of the length of restriction fragments.
EFFECT: invention provides a simple, cheap, specific method which enables to identify functionally significant polymorphous gene loci, grow the number of analysed genes for further introduction into any standard clinical laboratory.
2 cl, 2 dwg, 3 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF DETERMINING PREDISPOSITION TO LONG PHYSICAL EFFORT | 2011 |
|
RU2468086C1 |
METHOD FOR PREDICTING CARDIO-VASCULAR DISEASES AND DIAGNOSTIC KIT FOR ITS IMPLEMENTATION | 2005 |
|
RU2304775C2 |
GENETIC PANEL AND METHOD FOR DETERMINATION OF PREDISPOSITION OF PERSON TO VARIOUS KINDS OF PHYSICAL WORKING CAPACITY | 2006 |
|
RU2339701C2 |
METHOD OF ESTIMATING RISK OF METABOLIC SYNDROME DEVELOPMENT IN CHILDREN BASING ON GENETIC AND BIOCHEMICAL MARKERS | 2012 |
|
RU2492485C1 |
METHOD OF PROFESSIONAL SELECTION OF EMPLOYEES OF POWER DEPARTMENTS AND PERSONS WHOSE ACTIVITIES ARE ASSOCIATED WITH HIGH RISK TO LIFE AND HEALTH, FOR EFFECTIVE PERFORMANCE OF SERVICE ACTIVITIES IN EXTREME CONDITIONS | 2019 |
|
RU2741342C1 |
METHOD FOR GENETIC MARKER PREDICTION OF RISK OF GESTOSIS | 2010 |
|
RU2431842C1 |
METHOD OF GENETIC POLYMORPHISM ANALYSIS FOR CARRYING OUT POSTNATAL DNA-DIAGNOSTICS OF MUCOVISCIDOSIS | 2008 |
|
RU2412247C2 |
METHOD FOR ANALYSIS OF GENETIC POLYMORPHYSM, DEFINING PREDISPOSITION TO TUMOR DISEASES AND INDIVIDUAL SENSITIVITY TO PHARMACEUTICAL AGENTS BY USING OLYGONUCLEOTIDE BIOLOGICAL MICROARRAY (BIOARRAY) | 2005 |
|
RU2303634C2 |
METHOD FOR PREDICTION OF HUMAN BODY LENGTH BY DNA ANALYSIS WITHIN RUSSIAN POPULATION | 2012 |
|
RU2531341C2 |
METHOD FOR DETECTING THE PREDISPOSITION TO ONCOLOGICAL DISEASES AND DIAGNOSTIC KIT FOR ITS IMPLEMENTATION | 2005 |
|
RU2296328C1 |
Authors
Dates
2011-03-20—Published
2008-12-09—Filed